Reprint

Dermatology: Advances on Pathophysiology and Therapies

Edited by
May 2024
232 pages
  • ISBN978-3-7258-0868-7 (Hardback)
  • ISBN978-3-7258-0867-0 (PDF)

This book is a reprint of the Special Issue Dermatology: Advances on Pathophysiology and Therapies that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

This reprint presents a meticulous compilation of 11 cutting-edge articles from leading authors in the field of dermatology, originally featured in our previous manuscript. This collection illustrates the significant advancements and innovations that have shaped dermatological science and practice in recent years.

Each article within this compendium delves into various aspects of dermatological advancements, ranging from the development of novel therapeutic approaches and understanding the genetic underpinnings of skin diseases to the exploration of new diagnostic tools and the integration of technology in dermatological care. The authors provide insightful analyses and discussions on the latest research findings, clinical trials, and emerging trends in dermatology.

This reprint reflects the dynamic and evolving nature of dermatology, showcasing the collaborative efforts of the global dermatological community to push the boundaries of knowledge and improve patient care. This collection of manuscripts stands as a cornerstone for those dedicated to the pursuit of excellence in dermatology, offering a perspective on the future of skin health and disease management.

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
chronic wound; electromagnetic fields; hypertrophic scar; keloid; laser; physical therapies; photobiomodulation; photodynamic therapy; radiofrequency; ultrasound therapy; wound healing; drug flux; Franz cell diffusion system; Strat-M® synthetic biomimetic membrane; HaCaT human skin cell line; NHEK human primary skin cells; EpiDerm® 3D human skin tissue; psoriasis; pharmacogenetics; pharmacogenomics; therapeutics; polymorphisms; toxicity; imiquimod; immunomodulation; immunotherapy; topical administration; skin neoplasms; actinic keratosis; basal cell carcinoma; melanoma; fibrosis; hypertrophic scar; keloids; radiofrequency; myofibroblast; metalloproteinase; extracellular matrix proteins; MAP-Kinases; NFκB; delayed drug hypersensitivity; skin reaction; SARS-CoV-2; LTT; interleukins; NMSC; Strat-M; HaCaT cell line; NHEK cells; cell viability; TEER; air–liquid interface; dermatosis; autoinflammatory; immunomodulation; therapy; autoimmune blistering diseases; bullous pemphigoid; drug-associated bullous pemphigoid; drug-induced bullous pemphigoid; dipeptidyl peptidase 4 inhibitors; gliptins; immunotherapy; immune checkpoint inhibitors; biologics; diuretics; psoriasis; inflammation; fibrosis; non-invasive; risk-assessment; vitiligo; JAK inhibitor; pathogenesis; therapeutics